Shutterstock/CNNMoney
Now playing
01:45
Here's why drug prices are so high (2018)
Now playing
04:22
Levi's CEO has message for Mitch McConnell
Elon Musk's Neuralink says this monkey is playing Pong with its mind
From Neuralink/Youtube
Elon Musk's Neuralink says this monkey is playing Pong with its mind
Now playing
01:41
Elon Musk's company says this monkey is playing Pong with his mind
CNN
Now playing
02:36
The truth behind Covid-19 vaccines for sale on the dark web
Heinz ketchup packets are shown in New York on Monday, August 22, 2005. H.J. Heinz Co., the world's biggest ketchup maker, said first-quarter profit fell 19 percent on expenses to cut jobs and sell businesses.  (Photo by Andrew Harrer/Bloomberg via Getty Images)
Andrew Harrer/Bloomberg/Getty Images
Heinz ketchup packets are shown in New York on Monday, August 22, 2005. H.J. Heinz Co., the world's biggest ketchup maker, said first-quarter profit fell 19 percent on expenses to cut jobs and sell businesses. (Photo by Andrew Harrer/Bloomberg via Getty Images)
Now playing
01:53
Restaurants face a nationwide ketchup packet shortage
CNN
Now playing
03:53
Norwegian Cruise Line CEO to CDC: We want to be treated fairly
Getty Images
Now playing
02:18
This airplane-shaped bag is selling for more than some actual planes
A medical worker prepares to administer a dose of the AstraZeneca vaccine in Belgrade, Serbia, Tuesday, March 23, 2021. American federal health officials say results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data. (AP Photo/Darko Vojinovic)
Darko Vojinovic/AP
A medical worker prepares to administer a dose of the AstraZeneca vaccine in Belgrade, Serbia, Tuesday, March 23, 2021. American federal health officials say results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data. (AP Photo/Darko Vojinovic)
Now playing
03:46
These are all the complications AstraZeneca's vaccine has faced
A driver rides his car in front of the Lyft Drivers Hub in Los Angeles, California, March 29, 2019. Ride-hailing company Lyft made its Initial Public Offering (IPO) on the Nasdaq Stock Market on March 29th. (Photo by Apu Gomes/AFP/Getty Images)
Apu Gomes/AFP/Getty Images
A driver rides his car in front of the Lyft Drivers Hub in Los Angeles, California, March 29, 2019. Ride-hailing company Lyft made its Initial Public Offering (IPO) on the Nasdaq Stock Market on March 29th. (Photo by Apu Gomes/AFP/Getty Images)
Now playing
04:55
Lyft co-founder: Supporting voter access is important for business
Citigroup Chairman Richard Parsons delivers remarks on the US economy at the New York State Bar Association meetings in New York, January 28, 2009. Troubled US banking giant Citigroup last week named Parsons as its new chairman, the longtime top executive at media giant Time Warner, to steer it through its most challenging period.  AFP PHOTO / Emmanuel Dunand (Photo credit should read EMMANUEL DUNAND/AFP via Getty Images)
EMMANUEL DUNAND/AFP/AFP via Getty Images
Citigroup Chairman Richard Parsons delivers remarks on the US economy at the New York State Bar Association meetings in New York, January 28, 2009. Troubled US banking giant Citigroup last week named Parsons as its new chairman, the longtime top executive at media giant Time Warner, to steer it through its most challenging period. AFP PHOTO / Emmanuel Dunand (Photo credit should read EMMANUEL DUNAND/AFP via Getty Images)
Now playing
02:47
Dick Parsons: Georgia law is a bald-faced attempt to suppress Black vote
Resturant Yurkevcih Pkg 1
CNN
Resturant Yurkevcih Pkg 1
Now playing
02:55
Restaurants are still struggling, but see hope on the horizon
WASHINGTON, DC - SEPTEMBER 16:  Patrick Soon-Shiong, chairman and CEO of the Institute for Advanced Health, participates in a discussion at the Bipartisan Policy Center, September 16, 2014 in Washington, DC.  The Bipartisan Policy Center released a report titled Innovative Strategies from America's Business Leaders.  (Photo by Mark Wilson/Getty Images)
Mark Wilson/Getty Images North America/Getty Images
WASHINGTON, DC - SEPTEMBER 16: Patrick Soon-Shiong, chairman and CEO of the Institute for Advanced Health, participates in a discussion at the Bipartisan Policy Center, September 16, 2014 in Washington, DC. The Bipartisan Policy Center released a report titled Innovative Strategies from America's Business Leaders. (Photo by Mark Wilson/Getty Images)
Now playing
04:04
Patrick Soon-Shiong: We have to recognize racism and 'break it'
ATLANTA, GA - MARCH 03: Demonstrators stand outside of the Georgia Capitol building, to oppose the HB 531 bill on March 3, 2021 in Atlanta, Georgia. HB 531 will add controversial voting restrictions to the state's upcoming elections including restricting ballot drop boxes, requiring an ID requirement for absentee voting and limiting weekend early voting days. The Georgia House passed the bill and will send it to the Senate. (Photo by Megan Varner/Getty Images)
Megan Varner/Getty Images
ATLANTA, GA - MARCH 03: Demonstrators stand outside of the Georgia Capitol building, to oppose the HB 531 bill on March 3, 2021 in Atlanta, Georgia. HB 531 will add controversial voting restrictions to the state's upcoming elections including restricting ballot drop boxes, requiring an ID requirement for absentee voting and limiting weekend early voting days. The Georgia House passed the bill and will send it to the Senate. (Photo by Megan Varner/Getty Images)
Now playing
02:24
Coca Cola, Delta Airlines strike back at Georgia voting laws
Now playing
03:08
'I want women to be as rich as humanly possible': Meet TikTok's wealth coaches
Now playing
05:41
NFTs have completely transformed these digital artists' lives
P&G
Now playing
01:45
This new P&G ad confronts stereotypes against Black Americans
(CNN) —  

Washington’s war on drug pricing is intensifying.

Newly empowered congressional Democrats moved Thursday to put forward their own solutions to prescription price hikes, a legislative counter to President Donald Trump’s own efforts from the White House to bring pharmaceutical manufacturers to heel.

Sen. Bernie Sanders, the Vermont independent, Rep. Elijah Cummings, Democrat of Maryland, and a group of Democratic lawmakers on Thursday unveiled a legislative package that included two longtime Democratic proposals that have been introduced in prior sessions.

It comes a day after Sens. Chuck Grassley, Republican of Iowa, and Amy Klobuchar, Democrat of Minnesota, teamed up to introduce a bill that would allow the importation of prescription drugs from approved pharmacies in Canada.

The Sanders-led effort calls for allowing pharmacies, individuals and wholesalers to import drugs from Canada, and eventually from countries in the Organization for Economic Cooperation and Development that meet US standards.

The other would allow the federal government to negotiate Medicare drug prices and to restrict the medications covered to enhance competition among drug makers.

In addition, Sanders and California Democrat Rep. Ro Khanna are rolling out the Prescription Drug Price Relief Act, which would require the federal government to pay the same as the median price for a drug in Canada, the United Kingdom, France, Germany and Japan. This would lower the cost of brand name drugs by roughly 43%, and it would cut the price of certain medications by even more, according to Sanders.

The concept is similar to one floated by Trump in October. Under the International Pricing Index model, Medicare would set the reimbursement level for certain drugs administered in doctors’ offices and hospital outpatient centers at 126% of the average of what other countries pay. Sanders’ bill would extend that idea to millions more Americans and cover many more drugs.

“The United States pays by far the highest prices in the world for prescription drugs. This has created a health care crisis in which one in five American adults cannot afford to get the medicine they need,” Sanders said. “If the pharmaceutical industry will not end its greed, which is literally killing Americans, then we will end it for them.”

Controlling drug prices has been a priority for the Trump administration and lawmakers in both parties. The President has publicly castigated drug makers for raising prices, while the Department of Health & Human Services issued a series of proposals aimed at reining in costs.

Sixty pharmaceutical companies kicked off 2019 by increasing list prices on nearly 300 drugs, according to an analysis by Rx Savings Solutions, which sells software to employers and insurers. And more manufacturers are expected to quietly follow suit in coming weeks – a delay experts say appears calculated to avoid attracting undue attention from Washington.

Companies seem to be tempering their hikes in 2019. The average increase was 6.3%, down from nearly 9% a year ago, taking into account different dosages of the same drug.

Still, the latest round of price increases has raised Trump’s ire. He lambasted drug makers over the weekend, saying they are not being fair to consumers or the nation.

The President also called in HHS Secretary Alex Azar to discuss the matter on Tuesday. The next day, Azar went on Fox Business and issued a series of tweets slamming the drug industry and promising to work with both Republicans and Democrats to reduce prices.

Tackling drug prices is one of the few areas that might produce bipartisan legislation.

Joint efforts aren’t new. Last year, Grassley and Klobuchar, along with the late Sen. John McCain of Arizona, urged the Department of Health & Human Services to fast-track the importation of drugs from Canada in certain circumstances to counter drastic drug price increases in the US.

“It’s long past time for Congress to help the millions of Americans who struggle to pay exorbitant prices for medication,” Grassley, chair of Senate Finance Committee said Wednesday.